NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

No biopsies,..... well that eliminates NWBO!
Stop the ridiculous dreaming

Stop the ridiculous BS!

Dr Nel Syed, who leads our Centre at Imperial, said: "A non-invasive, inexpensive method for the early detection of brain tumours is critical for improvements in patient care. There is still some way to go, but this solution could help people where a brain biopsy or surgical resection of the tumour is not possible due to the location of the tumour or other constraints. Through this technology, a diagnosis of inaccessible tumours can become possible through a risk-free and patient-friendly blood test. We believe this could be a world-first as there are currently no non-invasive or non-radiological tests for this type of tumour."

Inoperable solid tumors : DCVax-Direct.
Linda Powers:

The Company also had positive results in its Phase 1 trial of DCVax-Direct, in which more than a dozen diverse types of inoperable solid tumors were treated. DCVax-Direct involves essentially the same mechanism of action as DCVax-L, except that the tumor target proteins are taken up by the dendritic cells in situ in the tumor following intra-tumoral injection, rather than from tumor lysate from a surgically resected tumor tissue sample. The Company looks forward to resuming its clinical development of DCVax-Direct for a wide range of inoperable solid tumors.

https://nwbio.com/northwest-biotherapeutics-announces-marketing-authorization-applications-submitted-uk-mhra-dcvax-l-glioblastoma/

In our brain tumour campaigning blog this week there are questions from @PaulJSweeney and @DanCardenMP, a blood test breakthrough and we talk to our ‘critical friends’ ➡️ https://t.co/Vbwj5iO2Hc #BrainTumourResearch #Campaigning #BrainTumour pic.twitter.com/WOj8JUg3CD

— Brain Tumour Research (@braintumourrsch) January 28, 2024